呼吸器内治療装置市場- 世界の産業規模、シェア、動向、機会、予測、装置別、エンドユーザー別、専門医別、地域別、競合別、2020-2030F

呼吸器内治療装置の世界市場規模は2024年に14億5,000万米ドルとなり、予測期間では2030年までCAGR 5.33%で力強い成長が予測されています。

COVID-19パンデミックは当初、呼吸器市場に大きな影響を与えました。しかし、政府の取り組みや政策、また不足を克服するための企業の戦略的開拓の結果、呼吸器デバイス市場は大きく成長しました。例えば、2021年5月、世界基金はインドのCOVID-19危機への対応を支援するため、7,500万米ドルの迅速な資金提供を承認しました。この新たな資金は、インドが酸素濃縮装置と圧力スイング吸着（PSA）酸素プラントを購入し、同国の中期的な医療用酸素のニーズを満たすのに役立ちました。したがって、COVID-19患者の急増により、呼吸器用機器の需要が増加し、市場の成長に拍車がかかりました。しかし、COVID-19の使用事例が減少し、パンデミックが呼吸器デバイスの使用を加速させたため、調査対象市場は調査対象期間中安定した成長を予測されるようになりました。例えば、WHOによると、肺がんは世界のがん死亡原因の第1位であり、その85％は喫煙が原因です。高リスク者の早期検診は生存率を向上させ、タバコの規制や環境リスク因子の低減などの一次予防対策は罹患率を下げ、命を救う上で極めて重要です。

市場促進要因

呼吸器疾患の有病率の上昇

主な市場課題

呼吸器内治療装置の高コスト

主な市場動向

低侵襲技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の呼吸器内治療装置市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 機器別（診断機器、治療機器）
  • エンドユーザー別（末梢血管インターベンション、血管内インターベンション、心臓、インターベンショナルラジオロジー、静脈、その他）
  • 専門医別（病院、診断センター、外来手術センター）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2024）
• 市場マップ
• デバイス別
• エンドユーザー別
• 専門家別
• 地域別

第6章 北米の呼吸器内治療装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の呼吸器内治療装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の呼吸器内治療装置市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の呼吸器内治療装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの呼吸器内治療装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界の呼吸器内治療装置市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Fujifilm Holdings Corporation.
• Medtronic plc.
• Johnson & Johnson.
• Smith & Nephew Plc.
• Stryker corporation.
• Olympus corporation.
• Hoya corporation.
• Steris Healthcare.
• Conmed corporation.
• Boston Scientific corporation.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Respiratory Endotherapy Devices Market was valued at USD 1.45 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 5.33% through 2030. The COVID-19 pandemic had a substantial impact on the respiratory devices market initially. However, the respiratory device market grew significantly as a result of government initiatives and policies, as well as the company's strategic developments to overcome the shortfall. For instance, in May 2021, the Global Fund approved USD 75 million in fast-track funding to support India's response to the COVID-19 crisis. This new funding helped India purchase oxygen concentrators and pressure swing adsorption (PSA) oxygen plants to help meet the country's medium-term medical oxygen needs. Hence, due to the surge in COVID-19 cases, the demand for respiratory devices increased, thereby fueling the growth of the market. However, as COVID-19 cases declined and the pandemic accelerated the use of respiratory devices, the studied market is now expected to project stable growth over the studied period. For instance, according to WHO, lung cancer is the leading cause of cancer deaths globally, with smoking responsible for 85% of cases. Early screening of high-risk individuals can improve survival rates, while primary prevention measures, such as tobacco control and reducing environmental risk factors, are crucial in lowering incidence and saving lives.

Key Market Drivers

Rising Prevalence of Respiratory Disorders

The escalating incidence of respiratory disorders worldwide is poised to propel the expansion of the Global Respiratory Endotherapy Devices Market. The rising prevalence of conditions such as chronic obstructive pulmonary disease (COPD), asthma, and respiratory infections is fostering an increased demand for advanced therapeutic interventions. Respiratory endotherapy devices play a pivotal role in the management of these disorders, offering minimally invasive and targeted treatments. For instance, According to the U.S. Centers for Disease Control and Prevention (CDC), smoking is responsible for approximately 8 out of 10 COPD-related deaths. Additionally, increasing levels of indoor and outdoor air pollution, along with exposure to dust and harmful chemicals, are significant contributors to the rising prevalence of COPD. As the global population ages and environmental factors contribute to respiratory health challenges, the need for effective and efficient endotherapy solutions is becoming more pronounced. The market is witnessing a surge in technological innovations, including bronchoscopes, tracheoscopes, and other endoscopic devices, which enhance diagnostic accuracy and treatment precision. Healthcare providers are increasingly adopting these devices to address respiratory issues, contributing to the overall market growth. The growing awareness among patients and healthcare professionals regarding the benefits of endotherapy, such as reduced recovery times and improved patient outcomes, is driving the uptake of these devices. In conclusion, the escalating burden of respiratory disorders, coupled with technological advancements in endotherapy, is anticipated to foster significant growth in the Global Respiratory Endotherapy Devices Market in the coming years.

Key Market Challenges

High Cost of Respiratory Endotherapy Devices

The high cost associated with respiratory endotherapy devices is anticipated to pose a significant impediment to the growth of the Global Respiratory Endotherapy Devices Market. The substantial financial investment required for acquiring these sophisticated medical devices can act as a deterrent for healthcare institutions, particularly in regions with constrained healthcare budgets. The intricate technology and specialized materials involved in manufacturing respiratory endotherapy devices contribute to their elevated price point, limiting accessibility for certain healthcare facilities and hindering widespread adoption. The financial burden on patients seeking respiratory treatments may curb patient acceptance and usage. High device costs often translate to increased procedural expenses, potentially affecting reimbursement policies and posing challenges for both healthcare providers and patients. Market players need to address these cost-related concerns through strategic initiatives such as research and development aimed at cost reduction, exploring partnerships for shared investments, and advocating for favorable reimbursement policies. Mitigating the economic barriers associated with respiratory endotherapy devices is crucial for fostering market growth and ensuring broader access to these advanced medical solutions in the evolving landscape of respiratory healthcare.

Key Market Trends

Advancements in Minimally Invasive Technologies

The growth trajectory of the Global Respiratory Endotherapy Devices Market is poised to be significantly steered by continual advancements in minimally invasive technologies. As medical science evolves, there is a paradigm shift towards procedures that offer reduced patient trauma, shorter recovery times, and enhanced precision. Respiratory endotherapy devices are at the forefront of this transformative trend, providing cutting-edge solutions for the diagnosis and treatment of respiratory disorders with minimal invasiveness. Innovations in endoscopic technologies, including the development of high-definition imaging and advanced navigation systems, empower healthcare practitioners to conduct intricate respiratory procedures with unprecedented clarity and accuracy. The integration of robotics and artificial intelligence further augments the capabilities of respiratory endotherapy devices, enabling more precise interventions and personalized treatment strategies. This technological evolution not only enhances the efficacy of respiratory procedures but also contributes to increased patient acceptance. As the global healthcare landscape embraces these advancements, the demand for state-of-the-art respiratory endotherapy devices is expected to rise, driving market growth. In essence, the continual refinement of minimally invasive technologies is a pivotal catalyst propelling the expansion of the Global Respiratory Endotherapy Devices Market, shaping the future of respiratory healthcare.

Key Market Players

• Fujifilm Holdings Corporation.
• Medtronic plc.
• Johnson & Johnson.
• Smith & Nephew Plc.
• Stryker corporation.
• Olympus corporation.
• Hoya corporation.
• Steris Healthcare.
• Conmed corporation.
• Boston Scientific corporation.

Report Scope:

In this report, the Global Respiratory Endotherapy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Respiratory Endotherapy Devices Market, By Devices:

• Diagnostic Devices
• Therapeutic Devices

Respiratory Endotherapy Devices Market, By End User:

• Peripheral Vascular Intervention
• Endovascular Interventions
• Cardiac
• Interventional Radiology
• Venous
• Others

Respiratory Endotherapy Devices Market, By Specialist:

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers

Respiratory Endotherapy Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Respiratory Endotherapy Devices Market.

Available Customizations:

Global Respiratory Endotherapy Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Respiratory Endotherapy Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
    • 5.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
    • 5.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
  • 5.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
  • 5.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Devices
• 5.3.2 By End User
• 5.3.3 By Specialist
• 5.3.4 By Region

6. North America Respiratory Endotherapy Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
    • 6.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
    • 6.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
  • 6.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
  • 6.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Respiratory Endotherapy Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Devices
      • 6.3.1.2.2. By End User
      • 6.3.1.2.3. By Specialist
  • 6.3.2. Canada Respiratory Endotherapy Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Devices
      • 6.3.2.2.2. By End User
      • 6.3.2.2.3. By Specialist
  • 6.3.3. Mexico Respiratory Endotherapy Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Devices
      • 6.3.3.2.2. By End User
      • 6.3.3.2.3. By Specialist

7. Europe Respiratory Endotherapy Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
    • 7.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
    • 7.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
  • 7.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
  • 7.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Respiratory Endotherapy Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Devices
      • 7.3.1.2.2. By End User
      • 7.3.1.2.3. By Specialist
  • 7.3.2. Germany Respiratory Endotherapy Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Devices
      • 7.3.2.2.2. By End User
      • 7.3.2.2.3. By Specialist
  • 7.3.3. United Kingdom Respiratory Endotherapy Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Devices
      • 7.3.3.2.2. By End User
      • 7.3.3.2.3. By Specialist
  • 7.3.4. Italy Respiratory Endotherapy Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Devices
      • 7.3.4.2.2. By End User
      • 7.3.4.2.3. By Specialist
  • 7.3.5. Spain Respiratory Endotherapy Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Devices
      • 7.3.5.2.2. By End User
      • 7.3.5.2.3. By Specialist

8. Asia-Pacific Respiratory Endotherapy Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
    • 8.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
    • 8.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
  • 8.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
  • 8.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Respiratory Endotherapy Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Devices
      • 8.3.1.2.2. By End User
      • 8.3.1.2.3. By Specialist
  • 8.3.2. India Respiratory Endotherapy Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Devices
      • 8.3.2.2.2. By End User
      • 8.3.2.2.3. By Specialist
  • 8.3.3. Japan Respiratory Endotherapy Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Devices
      • 8.3.3.2.2. By End User
      • 8.3.3.2.3. By Specialist
  • 8.3.4. South Korea Respiratory Endotherapy Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Devices
      • 8.3.4.2.2. By End User
      • 8.3.4.2.3. By Specialist
  • 8.3.5. Australia Respiratory Endotherapy Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Devices
      • 8.3.5.2.2. By End User
      • 8.3.5.2.3. By Specialist

9. South America Respiratory Endotherapy Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
    • 9.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
    • 9.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
  • 9.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
  • 9.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Respiratory Endotherapy Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Devices
      • 9.3.1.2.2. By End User
      • 9.3.1.2.3. By Specialist
  • 9.3.2. Argentina Respiratory Endotherapy Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Devices
      • 9.3.2.2.2. By End User
      • 9.3.2.2.3. By Specialist
  • 9.3.3. Colombia Respiratory Endotherapy Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Devices
      • 9.3.3.2.2. By End User
      • 9.3.3.2.3. By Specialist

10. Middle East and Africa Respiratory Endotherapy Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
    • 10.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
    • 10.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
  • 10.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
  • 10.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Respiratory Endotherapy Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Devices
      • 10.3.1.2.2. By End User
      • 10.3.1.2.3. By Specialist
  • 10.3.2. Saudi Arabia Respiratory Endotherapy Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Devices
      • 10.3.2.2.2. By End User
      • 10.3.2.2.3. By Specialist
  • 10.3.3. UAE Respiratory Endotherapy Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Devices
      • 10.3.3.2.2. By End User
      • 10.3.3.2.3. By Specialist

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Respiratory Endotherapy Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Fujifilm Holdings Corporation.
  • 15.1.1. Business Overview
  • 15.1.2. Product Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Key Personnel
  • 15.1.6. SWOT Analysis
• 15.2. Medtronic plc.
• 15.3. Johnson & Johnson.
• 15.4. Smith & Nephew Plc.
• 15.5. Stryker corporation.
• 15.6. Olympus corporation.
• 15.7. Hoya corporation.
• 15.8. Steris Healthcare.
• 15.9. Conmed corporation.
• 15.10. Boston Scientific corporation.

16. Strategic Recommendations

17. About Us & Disclaimer